Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Tarun Krishna Boppana"'
Autor:
Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Randeep Guleria
Publikováno v:
Monaldi Archives for Chest Disease (2022)
The coronavirus disease 2019 (COVID-19) has affected different countries in a differential manner. The host susceptibility and host factors are important parameters for this variability. This study aimed to assess the effect of tuberculosis (TB) ende
Externí odkaz:
https://doaj.org/article/68ffcb24fcc749938cd9a451b05a51b7
Autor:
Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Randeep Guleria
Publikováno v:
Monaldi Archives for Chest Disease (2022)
The effective treatment modalities for severe coronavirus disease 2019 (COVID-19) are needed. As the primary cause of mortality is a hyperinflammatory state, the interleukin-6 antagonist tocilizumab has been used in multiple clinical studies. We cond
Externí odkaz:
https://doaj.org/article/a92fc8a6e6834f16b104751d4100e527
Autor:
Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Pawan Tiwari, Randeep Guleria
Publikováno v:
Monaldi Archives for Chest Disease (2021)
There is an urgent need for effective treatment modalities for coronavirus disease 2019 (COVID-19). Data for the use of steroids in COVID-19 is emerging. We conducted this systematic review and meta-analysis to estimate the effectiveness of steroid a
Externí odkaz:
https://doaj.org/article/c908c276bf3d4cc0aa5d7459786ce7c8
Publikováno v:
Monaldi Archives for Chest Disease, Vol 91, Iss 1 (2021)
Dear Editor, There is an increasing pressure on healthcare systems around the globe since the onset of the current coronavirus disease 2019 (COVID-19) pandemic to cope up with the increasing workload...
Externí odkaz:
https://doaj.org/article/067be038cea94624b8fa27e42f94dfef
Publikováno v:
Lung India, Vol 38, Iss 1, Pp 84-85 (2021)
Externí odkaz:
https://doaj.org/article/c7626a4f0ecf48f1bd43d373d2027632
Publikováno v:
Lung India, Vol 37, Iss 3, Pp 283-284 (2020)
Externí odkaz:
https://doaj.org/article/bf1114b25aa44651a641e0125727a2d6
Publikováno v:
Lung India, Vol 36, Iss 5, Pp 449-450 (2019)
Externí odkaz:
https://doaj.org/article/30f2d010f14747d389015d769e779372
Autor:
Pawan Tiwari, Shweta Bhopale, Ved Prakash Meena, Sushil Suresh Shelke, Karan Madan, Rakesh Garg, Vijay Hadda, Angel Rajan Singh, Shelly Mahajan, Tarun Krishna Boppana, Ritu Gupta, Saurabh Mittal, Ujjalkumar Subhash Das, Shet Masih, Ravindra Mohan Pandey, Ankit Patel, Anant Mohan, Tejas M Suri, Biswajeet Sahoo, Randeep Guleria, Nishkarsh Gupta, Thirumurthy Velpandian, Tanima Dwivedi, Anuja Pandit, Sushma Bhatnagar, Saurabh Vig, Avinash Jain
Publikováno v:
Journal of Infection and Chemotherapy
Introduction Ivermectin is an antiparasitic drug which has in-vitro efficacy in reducing severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) viral load. Hence, Ivermectin is under investigation as a repurposed agent for treating COVID-19. Me
Autor:
Vijay Hadda, Saurabh Mittal, Karan Madan, Tarun Krishna Boppana, Anant Mohan, Randeep Guleria, Pawan Tiwari
Publikováno v:
Advances in respiratory medicine. 89(3)
Coronavirus disease 2019 (COVID-19) has emerged as a pandemic and has killed millions across the globe [...]
Publikováno v:
Advances in respiratory medicine. 89(1)
Since the onset of the current pandemic of coronavirus disease-19 (COVID-19) [...]